Trial Profile
A Phase 3 Randomized Study to Confirm the Efficacy of an Intra-Articular Injection of Ampion in Adults With Pain Due to Severe Osteoarthritis of the Knee
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 11 Aug 2022
Price :
$35
*
At a glance
- Drugs DMI 9523 (Primary)
- Indications Osteoarthritis
- Focus Registrational; Therapeutic Use
- Sponsors Ampio Pharmaceuticals
- 17 Jun 2021 Results presented in an Ampio Pharmaceuticals media release.
- 22 May 2019 Results presented in an Ampio Pharmaceuticals media release.
- 22 May 2019 According to an Ampio Pharmaceuticals media release, data from the study have been accepted as a podium presentation at the 83rd Annual Meeting of the Western Orthopedic Association (WOA) 2019.